ICICI Prudential Life: Maintain ‘buy’ with target price of Rs 790

By: |
April 21, 2021 8:29 AM

ICICI Prudential Life (IPru Life) reported NBP/APE growth of 23%/27% YoY in Q4FY21, following 3 straight quarters of decline. March month’s APE growth of 108% YoY was a standout.

ICICI Prudential Life, APE growth, Positive investment variance, maintain buy, ULIP growthIPru Life plans to compensate for this by increasing attachment of riders and higher traction on group segment.

ICICI Prudential Life (IPru Life) reported NBP/APE growth of 23%/27% YoY in Q4FY21, following 3 straight quarters of decline. March month’s APE growth of 108% YoY was a standout. This acceleration in momentum (key to stock re-rating) is driven by both its enhanced product suite as well as its augmented distribution capabilities. FY21 VNB margin improved 340bps to 25.1%, primarily through business mix (higher share of annuity/protection). Growth expectations bolstered by ULIP recovery (11% YoY in Q4) should drive VNB. Positive investment variance (11% of FY20 EV) drives 10%/8% upgrade in FY22E/23E EV. Maintain ‘BUY’ with revised TP of Rs 790 (Rs 720 earlier; multiple unchanged at 3.4x FY22E P/EV).

ULIP has grown YoY after a straight seven quarter gap, while sales of non-linked savings and annuity continued to clock robust performance. Protection dipped 3% in Q4FY21 as near-term headwinds in the form of price hikes and reluctance for medical check-ups affected retail momentum. However, IPru Life plans to compensate for this by increasing attachment of riders and higher traction on group segment. Adding bank partners like IDFC First, Indusind, RBL and AU has started paying off as contribution of non-ICICI Bank partners jumped >2x from 5% of APE in FY20 to 11% in FY21. While sales from ICICI Bank had been slow for 9mFY21, even this channel ended Q4FY21 with a 50% YoY jump. Agency, direct & partnerships also printed strong growth of their own; a true example of broad spectrum growth delivery.

Outlook and valuations: Growth resumption; maintain ‘BUY’ ULIP growth in earnest may require cyclical support, but market share recapture in the same and resumption of protection momentum seem likely. At CMP, the stock trades at an attractive 2.0x P/EV FY22E.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1JSW Hydro Energy raises USD 707 mn via green bonds overseas
2Blackstone-backed Sona BLW Precision Forgings gets SEBI nod for IPO; plans to raise Rs 6,000 crore
3Gold price today, 11 May 2021: Gold trades flat, follows international trends; check intraday strategies